Original Article

A Novel Function for the Tumor Suppressor p16^INK4a: Induction of Anoikis via Upregulation of the ₅ß₁ Fibronectin Receptor

Correspondence to: Stefan Rosewicz, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany. Tel:49-30-450-53733 Fax:49-30-450-53940

The tumor suppressor gene p16^INK4a inhibits the kinase activity of the cyclin-dependent kinase 4–6/cyclin D complexes and subsequent phosphorylation of critical substrates necessary for transit through the G1 phase of the cell cycle. Recent studies suggested that control of the G1/S boundary might not be the sole biological function of p16^INK4a. We hypothesized that p16^INK4a might influence hitherto unknown critical features of a malignant epithelial phenotype, such as anchorage dependence. Here we provide evidence that stable transfection of p16^INK4a restitutes apoptosis induction upon loss of anchorage (anoikis) in a variety of human cancer cells. Anoikis in p16^INK4a-transfected cells was evidenced by DNA fragmentation and poly(ADP-ribose) polymerase cleavage upon cultivation on polyhydroxyethylmethacrylate-coated dishes and was associated with suppression of anchorage-independent growth as well as complete loss of tumorigenicity. p16^INK4a-mediated anoikis was due to selective transcriptional upregulation of the ₅ integrin chain of the ₅ß₁ fibronectin receptor as detected by FACS^® analysis, immunoprecipitation, Northern blotting, and nuclear run-on assays. Addition of soluble fibronectin and inhibitory ₅ antibodies to nonadherent cells completely abolished p16^INK4a-mediated anoikis, whereas laminin was ineffective. Furthermore, antisense-induced downregulation of the ₅ integrin chain in p16^INK4a-transfected cells restored resistance to anoikis. These data suggest a novel functional interference between a cell cycle–regulating tumor suppressor gene and membrane-bound integrins, thus regulating a hallmark feature of an epithelial transformed phenotype: susceptibility to anoikis.

Key Words: tumor suppressor p16^INK4a, anoikis, fibronectin, integrin, tumorigenicity

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Marongiu, F., Doratiotto, S., Montisci, S., Pani, P., Laconi, E. (2008). Liver Repopulation and Carcinogenesis: Two Sides of the Same Coin?. Am. J. Pathol. 172: 857-864 [Abstract] [Full Text]  
• Rao, J. S., Bhoopathi, P., Chetty, C., Gujrati, M., Lakka, S. S. (2007). MMP-9 Short Interfering RNA Induced Senescence Resulting in Inhibition of Medulloblastoma Growth via p16INK4a and Mitogen-Activated Protein Kinase Pathway. Cancer Res. 67: 4956-4964 [Abstract] [Full Text]  
• Fischer, C., Sanchez-Ruderisch, H., Welzel, M., Wiedenmann, B., Sakai, T., Andre, S., Gabius, H.-J., Khachigian, L., Detjen, K. M., Rosewicz, S. (2005). Galectin-1 Interacts with the {alpha}5{beta}1 Fibronectin Receptor to Restrict Carcinoma Cell Growth via Induction of p21 and p27. J. Biol. Chem. 280: 37266-37277 [Abstract] [Full Text]  
• Chapman, E. J., Harnden, P., Chambers, P., Johnston, C., Knowles, M. A. (2005). Comprehensive Analysis of CDKN2A Status in Microdissected Urothelial Cell Carcinoma Reveals Potential Haploinsufficiency, a High Frequency of Homozygous Co-deletion and Associations with Clinical Phenotype. Clin. Cancer Res. 11: 5740-5747 [Abstract] [Full Text]  
• Hauff, P., Seemann, S., Reszka, R., Schultze-Mosgau, M., Reinhardt, M., Buzasi, T., Plath, T., Rosewicz, S., Schirner, M. (2005). Evaluation of Gas-filled Microparticles and Sonoporation as Gene Delivery System: Feasibility Study in Rodent Tumor Models. Radiology 236: 572-578 [Abstract] [Full Text]  
• Lee, I., Skinner, M. A., Guo, H.-b., Sujan, A., Pierce, M. (2004). Expression of the Vacuolar H+-ATPase 16-kDa Subunit Results in the Triton X-100-insoluble Aggregation of {beta}1 Integrin and Reduction of Its Cell Surface Expression. J. Biol. Chem. 279: 53007-53014 [Abstract] [Full Text]  
• Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., DePinho, R. A. (2003). Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 17: 3112-3126 [Abstract] [Full Text]  
• Lee, A. W. C., Li, J.-H., Shi, W., Li, A., Ng, E., Liu, T.-J., Klamut, H. J., Liu, F.-F. (2003). p16 Gene therapy: A potentially efficacious modality for nasopharyngeal carcinoma. Molecular Cancer Therapeutics 2: 961-969 [Abstract] [Full Text]  
• Martin, J. A., Forest, E., Block, J. A., Klingelhutz, A. J., Whited, B., Gitelis, S., Wilkey, A., Buckwalter, J. A. (2002). Malignant Transformation in Human Chondrosarcoma Cells Supported by Telomerase Activation and Tumor Suppressor Inactivation. Cell Growth Differ. 13: 397-407 [Abstract] [Full Text]  
• Hosotani, R., Miyamoto, Y., Fujimoto, K., Doi, R., Otaka, A., Fujii, N., Imamura, M. (2002). Trojan p16 Peptide Suppresses Pancreatic Cancer Growth and Prolongs Survival in Mice. Clin. Cancer Res. 8: 1271-1276 [Abstract] [Full Text]  
• Schwartz, M. A., Assoian, R. K. (2002). Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J. Cell Sci. 114: 2553-2560 [Abstract] [Full Text]  
• Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M., Cheresh, D. A. (2001). Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155: 459-470 [Abstract] [Full Text]  
• Lubomierski, N., Kersting, M., Bert, T., Muench, K., Wulbrand, U., Schuermann, M., Bartsch, D., Simon, B. (2001). Tumor Suppressor Genes in the 9p21 Gene Cluster Are Selective Targets of Inactivation in Neuroendocrine Gastroenteropancreatic Tumors. Cancer Res. 61: 5905-5910 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents